Refine Results
  1. "JNCI
Formats
  1. Journal Article (395)
  2. Editorial (14)
  3. Correspondence (2)
  4. Guidelines (2)
  5. Review (2)
Groups
  1. Department of Medicine (159)
  2. Solid Tumor Oncology Division (134)
  3. Population Sciences Research Program (116)
  4. Epidemiology and Biostatistics (91)
  5. Survivorship Research (91)
  6. Surgery (64)

More Groups

People
  1. Leonard Saltz (20)
  2. Kenneth Offit (18)
  3. Larry Norton (18)
  4. Mark Robson (18)
  5. Colin Begg (16)
  6. Carlos Cordon-Cardo (15)

More People

Years
  1. 2022 (11)
  2. 2021 (22)
  3. 2020 (16)
  4. 2019 (15)
  5. 2018 (7)
  6. 2017 (11)

More Years

Publications
  1. JNCI: Journal of the National Cancer Institute (415)
Publishers
  1. Oxford University Press (415)

Results (415)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Determining PD-L1 status in patients with triple-negative breast cancer: Lessons learned from IMpassion130
    Review

    Badve, S. S.; Penault-Llorca, F.; Reis-Filho, J. S.; Deurloo, R.; Siziopikou, K. P.; D'Arrigo, C.; Viale, G.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Toward using breast cancer risk prediction models for guiding screening decisions
    Editorial

    Moskowitz, C. S.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Survival in young-onset metastatic colorectal cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80405
    Journal Article

    Lipsyc-Sharf, M.; Zhang, S.; Ou, F. S.; Ma, C.; McCleary, N. J.; Niedzwiecki, D.; Chang, I. W.; Lenz, H. J.; Blanke, C. D.; Piawah, S.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Real-world use of bone-modifying agents in metastatic castration-sensitive prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Bach, P. B.; Morris, M. J.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Breast and prostate cancer risks for male BRCA1 and BRCA2 pathogenic variant carriers using polygenic risk scores
    Journal Article

    Barnes, D. R.; Silvestri, V.; Leslie, G.; McGuffog, L.; Dennis, J.; Yang, X.; Adlard, J.; Agnarsson, B. A.; Ahmed, M.; Aittomäki, K.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Breast cancer screening among childhood cancer survivors treated without chest radiation: Clinical benefits and cost-effectiveness
    Journal Article

    Yeh, J. M.; Lowry, K. P.; Schechter, C. B.; Diller, L. R.; O'Brien, G.; Alagoz, O.; Armstrong, G. T.; Hampton, J. M.; Hudson, M. M.; Leisenring, W.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Association of genetic testing results with mortality among women with breast cancer or ovarian cancer
    Journal Article

    Kurian, A. W.; Abrahamse, P.; Bondarenko, I.; Hamilton, A. S.; Deapen, D.; Gomez, S. L.; Morrow, M.; Berek, J. S.; Hofer, T. P.; Katz, S. J.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Does artificial intelligence meaningfully enhance cystoscopy?
    Editorial

    Lenis, A. T.; Litwin, M. S.
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Longitudinal changes in cognitive function in a nationwide cohort study of patients with lymphoma treated with chemotherapy
    Journal Article

    Janelsins, M. C.; Mohamed, M.; Peppone, L. J.; Magnuson, A.; Belcher, E. K.; Melnik, M.; Dakhil, S.; Geer, J.; Kamen, C.; Minasian, L.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save
  • Reevaluating disease-free survival as an endpoint vs overall survival in stage III adjuvant colon cancer trials
    Journal Article

    Yin, J.; Salem, M. E.; Dixon, J. G.; Jin, Z.; Cohen, R.; DeGramont, A.; Van Cutsem, E.; Taieb, J.; Alberts, S. R.; Wolmark, N.; more...
    JNCI: Journal of the National Cancer Institute (2022)

    Fulltext@MSK | Save